In a time of increasingly bespoke healthcare, Elizabeth Philp has become a formidable figure of innovation, particularly in the tech-driven field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the vanguard of a push to make tailor-made medications more accessible, challenging the traditional one-size-fit